Coolcat: Medical Momentum
07/25/2003 12:00 am EST
Kevin Kennedy's The Coolcat Report focuses on momentum to isolate its buy candidates. To be a "Low Price Momentum" buy, a stock must show relative strength of 99 and trade below 15. To earn a "Super Seven" designation, it must meet seven criteria, such as a new price high, a breakout in volume, and a move above a technical base. The latest buys in both categories are medical technology plays.
"Our latest new listing among our 'Low Price Momentum' stocks is Vascular Solutions (VASC NASDAQ), which has risen from a low near $1 to over $4 per share. Vascular is an interventional medical device company with a focus on sealing technologies. Its primary product is the Duett sealing device, which combines an easy-to-use balloon catheter delivery mechanism with a biological procoagulant mixture to enable cardiologists and radiologists to rapidly seal the puncture site following catheterization procedures such as angiography, angioplasty, and stenting.
"Our latest 'Super Seven' is Candela (CLZR NASDAQ), which has risen from $3.32 to above $14. Candela manufactures and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 60 countries from offices in the US, Europe, Japan, and other Asian locations. Candela established the aesthetic laser market 14 years ago and currently has an installed base of over 6,000 lasers worldwide."